KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Accounts Payables (2016 - 2026)

Neogenomics filings provide 17 years of Accounts Payables readings, the most recent being $25.9 million for Q1 2026.

  • On a quarterly basis, Accounts Payables rose 59.76% to $25.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $25.9 million, a 59.76% increase, with the full-year FY2025 number at $23.1 million, up 6.86% from a year prior.
  • Accounts Payables hit $25.9 million in Q1 2026 for Neogenomics, up from $23.1 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $27.5 million in Q2 2025 to a low of $13.7 million in Q3 2022.
  • Median Accounts Payables over the past 5 years was $20.3 million (2023), compared with a mean of $19.9 million.
  • Biggest five-year swings in Accounts Payables: crashed 51.96% in 2022 and later surged 59.97% in 2025.
  • Neogenomics' Accounts Payables stood at $20.5 million in 2022, then dropped by 0.86% to $20.3 million in 2023, then rose by 6.26% to $21.6 million in 2024, then increased by 6.86% to $23.1 million in 2025, then rose by 12.16% to $25.9 million in 2026.
  • The last three reported values for Accounts Payables were $25.9 million (Q1 2026), $23.1 million (Q4 2025), and $22.6 million (Q3 2025) per Business Quant data.